- Location
hepatitis C
"-
Patients Can Be Easily Screened for Depression and Anxiety as They Wait for Care
Mar 5, 2014A new study in General Hospital Psychiatry finds patients visiting the hospital for a variety of ailments can be easily screened for depression and anxiety as they wait for care, information that can then be sent immediately to their doctor ...
Tags: Waiting room time, Depression, Anxiety
-
BMS Received Breakthrough Therapy Designation for Its Investigational DCV Dual Regimen
Feb 26, 2014Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment ...
Tags: Bristol-Myers, Medicine
-
Diasorin Obtains Marketing Approvals for Hepatitis, Retroviral and Syphilis Assays
Feb 7, 2014DiaSorin, a biotechnology company, has received all the marketing approvals for hepatitis, retroviral and syphilis assays on its Liaison XL platform for the Chinese market. DiaSorin is now entering the hepatitis B, hepatitis C and ...
Tags: DiaSorin, HCV, HIV, pre-surgical screening testing
-
Each Week, KHN Compiles a Selection of Recently Released Health Policy Studies and Briefs
Jan 21, 2014Each week, KHN compiles a selection of recently released health policy studies and briefs. Journal of the American Geriatrics Society: Hospitalization Of Elderly Medicaid Long-Term Care Users Who Transition From Nursing Homes To compare ...
-
Each Week, KHN Compiles a Selection of Recently Released Health Policy Studies and Briefs
Jan 20, 2014Each week, KHN compiles a selection of recently released health policy studies and briefs. Journal of the American Geriatrics Society: Hospitalization Of Elderly Medicaid Long-Term Care Users Who Transition From Nursing Homes To compare ...
-
J&J Found a Private Firm Willing to Pay $4.15 Billion for Clinical Diagnostics Division
Jan 17, 2014Johnson & Johnson has found a private equity firm willing to pay $4.15 billion for its Ortho Clinical Diagnostics division, which provides blood-testing equipment and chemicals. One would think that blood testing should be a booming ...
Tags: Get out of Blood Testing Tech, J&J
-
Hepatitis C Treatment Isn't Pretty
Jan 16, 2014Hepatitis C treatment isn't pretty, but the dark days of weekly injections, rough side effects and no guarantee of full recovery from the liver-damaging disease may soon be over, researchers report. Two studies, both published in the Jan. ...
-
Opioid Dependence Is a Risk Factor for HIV, Stis, and Hepatitis C Virus (HCV) Infection
Dec 27, 2013A survey of opioid treatment programs finds that the proportion offering on-site testing for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) declined substantially between 2000 and 2011, despite guidelines ...
Tags: opioid treatment programs, human immunodeficiency virus
-
People with Type 2 Diabetes Might Be at Somewhat Higher Risk of Developing Liver Cancer
Dec 26, 2013People with type 2 diabetes might be at somewhat higher risk of developing liver cancer, according to a large, long-term study. The research suggests that those with type 2 diabetes have about two to three times greater risk of developing ...
Tags: type 2 diabetes, liver cancer, hepatocellular carcinoma
-
Sovaldi Has Been Approved to Treat Chronic Infection with Hepatitis C
Dec 26, 2013Sovaldi (sofosbuvir) has been approved by the U.S. Food and Drug Administration to treat chronic infection with Hepatitis C. It's considered a breakthrough medication since it's the first such drug that does not require same-time ...
Tags: Sovaldi, chronic infection, Hepatitis C
-
Gilead Sciences Has Received Notice of Compliance From Health Canada
Dec 19, 2013Gilead Sciences has received notice of compliance from Health Canada for its once-daily oral nucleotide analog polymerase inhibitor Sovaldi or sofosbuvir 400mg tablets for the treatment of chronic hepatitis C or CHC infection. Sovaldi is ...
-
FDA Approved Sovaldi to Treat Chronic Hepatitis C Virus Infection Without Interferon
Dec 11, 2013The U.S. Food and Drug Administration approved Sovaldi -- sofosbuvir -- to treat chronic hepatitis C virus infection without interferon, officials say. Dr. Edward Cox, director of the Office of Antimicrobial Products in the FDA's Center ...
Tags: FDA, Sovaldi, sofosbuvir, chronic hepatitis C, health
-
FDA Has Approved Sovaldi 400mg Tablets
Dec 10, 2013Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection ...
Tags: Gilead Sciences, Chronic Hepatitis
-
The US Food and Drug Administration Has Granted Orphan Drug Designation
Dec 4, 2013The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
-
Biozone Pharmaceuticals Has Agreed to Terms and Signed a Letter of Intent to Merge
Nov 29, 2013US-based Biozone Pharmaceuticals has announced that it has agreed to terms and signed a letter of intent (LOI) to merge with Cocrystal Discovery, a privately-held biotechnology company developing antiviral therapeutics for human diseases. ...
Related Products
-
HCV Hepatitis C Virus Ab Test Cassette Antibody Rapid Test Kit
-
Testsealabs IVD Infectious Diseases HCV Hepatitis C Virus Ab Test Diagnostic Rapid Test
-
Testsealabs IVD Infectious Diseases HCV Hepatitis C Virus Ab Test Diagnostic Rapid Test
-
Factory Price HCV Strip Hepatitis C Virus Ab Test Cassette
-
Testsealabs Antigen Rapid Detection HCV Hepatitis C Virus Ab Serum Plasma Whole blood rapid Test
-
KHB Infectious Disease Diagnostic Kit for Hepatitis C Virus Antibody (Colloidal Gold) HCV Reagent Rapid Test
